cro.directory
← Compare landing

Cyagen Biosciences vs Avigen Ltd

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/apac-cyagen/avigen

CategoryCyagen BiosciencesAvigen Ltd
Listed sitecrocro
SummaryCyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical research, with specialized expertise in humanized mice, gene therapy vectors, and disease-specific models across oncology, neurology, and metabolic disorders.Avigen offers avidity-based profiling of live immune–target cell interactions for immunotherapy discovery and preclinical validation. Its platform supports TCR-T, CAR-T, and NK programmes across solid tumour indications.
Services
  • Specialized & Large-Animal Models
  • Preclinical In Vivo Studies
  • Preclinical In Vitro Studies
  • In Vivo Efficacy Models
  • Translational Research
  • Discovery Research
  • Discovery Research
  • Preclinical In Vitro Studies
Modalities
  • Biologics (Monoclonal Antibodies)
  • Oligonucleotide
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Cell Therapy
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Rare Disease
  • Ophthalmology
  • Oncology
Locations
  • Headquarters, Santa Clara, California, United States
  • White City (Scale Space), London, United Kingdom
Certifications
  • AAALAC · Identifier: AAALAC-accredited facilities
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.